Cargando…
Protocol for a randomized, placebo-controlled, double-blind clinical trial investigating sacral neuromodulation for neurogenic lower urinary tract dysfunction
BACKGROUND: Sacral neuromodulation has become a well-established and widely accepted treatment for refractory non-neurogenic lower urinary tract dysfunction, but its value in patients with a neurological cause is unclear. Although there is evidence indicating that sacral neuromodulation may be effec...
Autores principales: | Knüpfer, Stephanie C, Liechti, Martina D, Mordasini, Livio, Abt, Dominik, Engeler, Daniel S, Wöllner, Jens, Pannek, Jürgen, Kiss, Bernhard, Burkhard, Fiona C, Schneider, Marc P, Miramontes, Elena, Kessels, Alfons G, Bachmann, Lucas M, Kessler, Thomas M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139491/ https://www.ncbi.nlm.nih.gov/pubmed/25123172 http://dx.doi.org/10.1186/1471-2490-14-65 |
Ejemplares similares
-
Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series
por: Engeler, Daniel S., et al.
Publicado: (2015) -
Editorial Comment: Sacral neuromodulation for neurogenic Lower Urinary Tract Dysfunction
por: Averbeck, Marcio Augusto
Publicado: (2023) -
Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions
por: Pannek, Jürgen, et al.
Publicado: (2017) -
Is there a role for sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction?
por: Averbeck, Marcio Augusto, et al.
Publicado: (2020) -
Prostatic artery embolization versus conventional TUR-P in the treatment of benign prostatic hyperplasia: protocol for a prospective randomized non-inferiority trial
por: Abt, Dominik, et al.
Publicado: (2014)